Evidence map›Paper›PMID 39006229›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

Perioperative management and neuraxial analgesia in women with factor XI deficiency (<60 IU/dL): a French multicenter observational study of 314 pregnancies.

C Flaujac, D Faille, C Lavenu-Bombled, N Drillaud, D Lasne, P Billoir, C Desconclois, L Touzet, A Lebreton, I Diaz-Cau and 8 more

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

C FlaujacLaboratoire de biologie médicale, Secteur hémostase, Centre hospitalier de Versailles (André Mignot), Le Chesnay-Rocquencourt, France.
D FailleService d'hématologie biologique, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, hôpital Bichat, Paris, France.
C Lavenu-BombledService d'hématologie biologique, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
N DrillaudCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares, Centre hospitalier Universitaire, Nantes, France.
D LasneService d'hématologie biologique, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Hôpital Necker Enfants Malades, Paris, France.
P BilloirService d'hématologie biologique, Centre hospitalier universitaire de Rouen, Rouen, France.
C DesconcloisService d'hématologie biologique, Assistance Publique Hôpitaux de Paris, Hôpital Antoine Béclère, Université Paris-Saclay, Clamart, France.
L TouzetLaboratoire de biologie médicale, Centre hospitalier de Valencienne, Valencienne, France.
A LebretonService d'hématologie biologique, Centre hospitalier universitaire de Clermont Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.
I Diaz-CauService d'hématologie biologique, Centre hospitalier universitaire de Montpellier, Montpellier, France.
R d'OironCentre de Référence de l'Hémophilie et des Maladies Hémorragiques Constitutionnelles rares, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
M Giansily-BlaizotService d'hématologie biologique, Centre hospitalier universitaire de Montpellier, Montpellier, France.
B WibautCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares et Centre de Référence maladie de Willebrand, Centre hospitalier régional universitaire de Lille, Lille, France.
P BeurrierCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares, Centre hospitalier universitaire d'Angers, Angers, France.
F VolotCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares, Centre hospitalier universitaire de Dijon, Dijon, France.
L RugeriCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares, Hospices Civils de Lyon, Lyon, France.
V Roussel-RobertCentre de Ressources et de Compétences des Maladies Hémorragiques Constitutionnelles rares, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Hôpital Cochin, Paris, France.
E de RaucourtCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles rares, centre hospitalier de Versailles (André Mignot), Le Chesnay, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Factor (F)XI deficiency is a rare bleeding disorder with a poor correlation between bleeding tendency and FXI level. Management of pregnant women with FXI deficiency is not clearly established, especially regarding neuraxial analgesia (NA). Objectives: A retrospective multicenter observational study was conducted in French hemostasis centers on pregnant women with FXI of <60 IU/dL. Methods: Data to report were (i) FXI levels before pregnancy and at time of delivery, (ii) type of NA and delivery management modalities, and (iii) possible complications related to NA and bleeding complications. Results: Three hundred fourteen pregnancies in patients with FXI deficiency of <60 IU/dL were reported (from 20 centers); among them, 199 NA procedures have been completed (137 epidurals and 61 spinals, 1 had both). The period of childbirth was mostly from 2014 to 2020 (281/314; 89.5%). Congenital FXI deficiency was established with certainty by investigators in 32.8% patients ( Conclusion: Our data support the use of a 30 IU/dL FXI threshold for NA, as suggested by the French proposals published in August 2023.

Indexed as

bleedingepidural anesthesiafactor XIobservational studyspinal anesthesia

Identifiers

PMID39006229
PMCPMC11245963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.